Page last updated: 2024-08-24

gemcitabine and pd 407824

gemcitabine has been researched along with pd 407824 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arora, S; Azorsa, DO; Basu, GD; Bisanz, KM; Choudhary, A; Gonzales, IM; Henderson, MC; Kiefer, JA; Mousses, S; Trent, JM; Von Hoff, DD	1

Other Studies

1 other study(ies) available for gemcitabine and pd 407824

Article	Year
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. Journal of translational medicine, 2009, Jun-11, Volume: 7 Topics: Aged; Alkaloids; Antimetabolites, Antineoplastic; Carbazoles; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Deoxycytidine; Dose-Response Relationship, Drug; Electric Impedance; Enzyme Inhibitors; Female; Gemcitabine; Gene Silencing; Humans; Male; Middle Aged; Pancreatic Neoplasms; Protein Kinases; Reproducibility of Results; RNA Interference; RNA, Small Interfering; Transfection	2009

Article

Year

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

Journal of translational medicine, 2009, Jun-11, Volume: 7

Topics: Aged; Alkaloids; Antimetabolites, Antineoplastic; Carbazoles; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Deoxycytidine; Dose-Response Relationship, Drug; Electric Impedance; Enzyme Inhibitors; Female; Gemcitabine; Gene Silencing; Humans; Male; Middle Aged; Pancreatic Neoplasms; Protein Kinases; Reproducibility of Results; RNA Interference; RNA, Small Interfering; Transfection

2009